Source link : https://www.newshealth.biz/health-news/no-increased-risk-of-mace-in-ibd/
PHILADELPHIA — Patients with inflammatory bowel disease (IBD) don’t appear to face an increased risk of major adverse cardiovascular events (MACE) or venous thromboembolism (VTE) when taking Janus kinase inhibitors (JAKi), compared with anti-tumor necrosis factor (TNF) agents, according to a study presented at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting. In […]
Author : News Health
Publish date : 2024-11-19 12:04:43
Copyright for syndicated content belongs to the linked Source.